CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NEWROFEED is developing ADHD@Home, a personalized treatment device for children with Attention Deficit Hyperactivity Disorder. Utilizing EEG technology for real-time monitoring, it aims to provide effective neurofeedback training at home under specialist supervision.
NEWROFEED aims at setting a new standard of care for children suffering from Attention Deficit Hyperactivity Disorder (ADHD). ADHD@Home is the diagnosis and treatment medical device, developed by Mensia in project NEWROFEED, to achieve this goal.
In order to optimise success rates, ADHD@Home is based on an EEG biomarker-based personalised medicine approach to treat ADHD children with state-of-the-art personalized Neurofeedback Training.
This patient-centered solution is delivered at home, with…
MENSIA TECHNOLOGIES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
